A proof-of-principle study of split-course bridging radiotherapy prior to commercial CD19 CAR T-cell therapies for patients with relapsed or refractory B-cell lymphomas Meeting Abstract


Authors: Imber, B. S.; Palomba, M. L.; Yahalom, J.
Abstract Title: A proof-of-principle study of split-course bridging radiotherapy prior to commercial CD19 CAR T-cell therapies for patients with relapsed or refractory B-cell lymphomas
Meeting Title: 63rd Annual Meeting of the American Society for Radiation Oncology (ASTRO 2021)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 111
Issue: 3 Suppl.
Meeting Dates: 2021 Oct 24-27
Meeting Location: Chicago, IL
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2021-11-01
Start Page: e311
Language: English
ACCESSION: WOS:000715803800627
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2021.07.966
Notes: Meeting Abstract: 2630 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joachim Yahalom
    625 Yahalom
  2. Maria Lia Palomba
    415 Palomba
  3. Brandon Stuart Imber
    214 Imber